AG-490 (Tyrphostin B42): JAK2/STAT Pathway Dissection in Can
2026-07-31
AG-490 (Tyrphostin B42) empowers researchers to precisely inhibit JAK2/STAT and MAPK pathways, enabling advanced study of tumor immunology and macrophage polarization. This guide details applied workflows, innovative experimental setups, and practical troubleshooting to unlock the full potential of AG-490 in cancer research.
Safe DNA Gel Stain: High-Sensitivity DNA and RNA Gel Stain f
2026-07-30
Safe DNA Gel Stain delivers high-sensitivity nucleic acid detection with blue-light excitation, offering a less mutagenic and environmentally friendly alternative to ethidium bromide. Its streamlined protocol and compatibility with modern molecular workflows make it ideal for both routine and advanced applications in genomics and cloning.
Continuous Rotigotine Delivery for Parkinson’s and RLS: Clin
2026-07-30
This review outlines the development and clinical validation of the rotigotine transdermal system, which achieves continuous dopaminergic stimulation for Parkinson’s disease (PD) and restless legs syndrome (RLS). Key findings highlight improvements in both motor and non-motor symptoms, and inform the design of preclinical and translational studies using rotigotine as a dopamine D2/D3 receptor agonist.
Reelin-SFK Signaling Primes Ketamine’s Antidepressant Respon
2026-07-29
This study establishes that intact synaptic Reelin signaling, specifically through the Apoer2-Src family kinase (SFK) pathway, is essential for ketamine-induced synaptic plasticity and behavioral effects in mouse models. The findings highlight molecular determinants of variability in antidepressant response and suggest new avenues for both mechanistic studies and therapeutic targeting.
Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor An
2026-07-29
Wang et al. (2018) systematically dissected the entry mechanism of genotype III grass carp reovirus (GCRV104), establishing that clathrin-mediated, pH-dependent endocytosis is critical for infection of host cells. Their inhibitor-driven approach clarifies the cellular processes involved and guides the rational selection of pathway-specific probes for future aquatic virology research.
Capecitabine in Tumor Microenvironment Modeling: Assay Break
2026-07-28
Explore Capecitabine’s role as a N4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine prodrug in advanced tumor microenvironment models. This article delivers a new perspective on integrating Capecitabine into patient-derived assembloid systems for more predictive preclinical oncology research.
Dihydroethidium: Precision Superoxide Detection in Live Cell
2026-07-28
Dihydroethidium (DHE) from APExBIO empowers researchers with sensitive, reproducible superoxide detection, streamlining oxidative stress and apoptosis assays. This guide details advanced workflows, troubleshooting strategies, and practical insights inspired by recent breakthroughs in redox biology.
SIRT1 Activation Restores Mitochondrial Biogenesis in Prion
2026-07-27
Zhao et al. (2024) reveal that SIRT1 activation, particularly via resveratrol, counteracts mitochondrial dysfunction and apoptosis in N2a neuroblastoma cells exposed to a prion protein fragment. These findings clarify the PGC-1α/TFAM pathway’s role in neuronal resilience and inform strategies for targeting mitochondrial quality control in prion disease models.
Optimizing Fibrosis and Angiogenesis Assays with SAR131675 (
2026-07-27
This article guides biomedical researchers and lab technicians in leveraging SAR131675, a selective and ATP-competitive VEGFR-3 inhibitor (SKU B2301), to address critical challenges in cell-based and in vivo assays targeting lymphangiogenesis, angiogenesis, and fibrosis. Practical scenario-driven Q&As clarify experimental design, data interpretation, and product selection—anchored by peer-reviewed data and workflow insights for reproducibility.
Enzyme-Induced Hypoxia Activates NLRP3 Inflammasome in Uroth
2026-07-26
This study demonstrates that prolonged enzyme-induced hypoxia, but not short-term hypoxia, triggers NLRP3 inflammasome activation and inflammation in urothelial cells in vitro. The findings highlight the ROS/TXNIP/NLRP3 axis as a mechanistic link in bladder outlet obstruction pathology and suggest actionable targets for research on inflammation modulation.
Super-Enhancer RNA Drives NPC Metastasis via NPM1/c-Myc/NDRG
2026-07-25
This study elucidates how exposure to the carcinogen DNP induces a specific super-enhancer RNA (seRNA-NPCm), which promotes nasopharyngeal carcinoma metastasis through upregulation of NDRG1 via the NPM1/c-Myc complex. The findings provide mechanistic insight into enhancer-driven oncogenic pathways and highlight molecular targets for future research.
VEGFC–VEGFR-3 Axis Inhibition Attenuates NASH-Driven Fibrosi
2026-07-24
This study demonstrates that inhibition of the hepatocyte-derived VEGFC–VEGFR-3 signaling axis—using either naringin or genetic/pharmacological blockade—markedly reduces hepatic inflammation and fibrosis in a high-fat diet mouse model of NASH. These findings highlight VEGFR-3 as a mechanistically validated target for dissecting anti-fibrotic pathways in metabolic liver disease.
Caffeine (1,3,7-trimethylpurine-2,6-dione) in Applied Resear
2026-07-24
Caffeine's unique mechanism as an adenosine receptor antagonist empowers advanced workflows in cancer cell line inhibition and metabolic modulation. This guide details validated protocols, troubleshooting strategies, and new cross-domain opportunities, bridging foundational cellular research with emerging translational models.
ETV5 Links Epigenetic Modification to Prognosis in Pan-Cance
2026-07-23
This study uncovers ETV5 as a prognostic marker across multiple cancer types, highlighting its association with adverse outcomes and drug resistance, especially in hepatocellular carcinoma. The research integrates pan-cancer transcriptomic analysis and functional validation, revealing ETV5's role in epigenetic regulation via EZH2 and implications for targeted epigenetic therapy.
Sulfachloropyridazine Modulates Cecal Microbiota in E. tenel
2026-07-23
This study delivers the first integrated analysis of sulfachloropyridazine, ethanamizuril, and their combination on cecal microbiota and metabolomics in chickens infected with Eimeria tenella. The findings reveal distinct, drug-specific shifts in microbial and metabolic profiles, informing approaches for monitoring anticoccidial efficacy and understanding antibiotic-microbiome interactions in poultry research.
458 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page